Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MEDI5395 |
Trade Name | |
Synonyms | recNDV-GM-CSF|MEDI 5395|MEDI-5395 |
Drug Descriptions |
MEDI5395 is an oncolytic virus that expresses GM-CSF, potentially resulting in enhanced antitumor immune response (Cancer Res July 1 2017 (77) (13 Supplement) 4556, PMID: 32088771). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C165457 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Durvalumab + MEDI5395 | Durvalumab MEDI5395 | 0 | 1 |
MEDI5395 | MEDI5395 | 0 | 1 |